Bioventus (BVS) Price to Earnings (2021 - 2026)

Bioventus (BVS) has reported Price to Earnings for 6 consecutive years, with 22.69 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 62.41% year-over-year to 22.69; the trailing twelve-month figure through Jun 2026 stood at 13.36 (up 101.2% YoY), and the FY2025 full-year result was 22.61, up 224.24% from the prior year.
• Price to Earnings declined to 22.69 in Q2 2026 per BVS's latest filing, from 189.01 in the prior quarter.
• Across five years, Price to Earnings topped out at 189.01 in Q1 2026 and bottomed at 1419.94 in Q4 2024.
• Historically, Price to Earnings has averaged 95.45 across 5 years, with a median of 21.58 in 2024.
• The sharpest annual moves came in 2024 and 2025: Price to Earnings plunged 13409.94% in 2024, then jumped 543.69% in 2025.
• Over 5 years, Price to Earnings stood at 4.53 in 2022, then sank by 1101.77% to 54.42 in 2023, then sank by 2509.37% to 1419.94 in 2024, then soared by 102.51% to 35.61 in 2025, then plunged by 36.28% to 22.69 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 22.69, 189.01, and 35.61 for Q2 2026, Q1 2026, and Q4 2025 respectively.